Literature DB >> 26035801

The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.

Scott D Grosse1, Glenn E Palomaki2, Mercy Mvundura3, Heather Hampel4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26035801      PMCID： PMC4511954          DOI： 10.1038/gim.2015.53

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  4 in total

1.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Authors:  Valérie Bonadona; Bernard Bonaïti; Sylviane Olschwang; Sophie Grandjouan; Laetitia Huiart; Michel Longy; Rosine Guimbaud; Bruno Buecher; Yves-Jean Bignon; Olivier Caron; Chrystelle Colas; Catherine Noguès; Sophie Lejeune-Dumoulin; Laurence Olivier-Faivre; Florence Polycarpe-Osaer; Tan Dat Nguyen; Françoise Desseigne; Jean-Christophe Saurin; Pascaline Berthet; Dominique Leroux; Jacqueline Duffour; Sylvie Manouvrier; Thierry Frébourg; Hagay Sobol; Christine Lasset; Catherine Bonaïti-Pellié
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

2.  Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation.

Authors:  D A Stupart; P A Goldberg; U Algar; R Ramesar
Journal:  Fam Cancer       Date:  2009-08-18       Impact factor: 2.375

3.  Economic evaluation of genetic screening for Lynch syndrome in Germany.

Authors:  Franziska Severin; Björn Stollenwerk; Elke Holinski-Feder; Elisabeth Meyer; Volker Heinemann; Clemens Giessen-Jung; Wolf Rogowski
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

4.  The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Authors:  Mercy Mvundura; Scott D Grosse; Heather Hampel; Glenn E Palomaki
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822
  4 in total
  9 in total

1.  Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.

Authors:  Jenna Petersen; Cathryn Koptiuch; Yelena P Wu; Ryan Mooney; Ashley Elrick; Kathryn Szczotka; Megan Keener; Lisa Pappas; Priyanka Kanth; Andrew Soisson; Wendy Kohlmann; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2018-07-26

2.  Genetic counseling and cascade genetic testing in Lynch syndrome.

Authors:  Heather Hampel
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 3.  Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

Authors:  M J Hall; E I Obeid; S C Schwartz; G Mantia-Smaldone; A D Forman; M B Daly
Journal:  Gynecol Oncol       Date:  2016-01-23       Impact factor: 5.482

4.  When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-09-24

5.  Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.

Authors:  Ying-Erh Chen; Sung-Shuo Kao; Ren-Hua Chung
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

6.  Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.

Authors:  Joanne Ngeow; Charis Eng
Journal:  NPJ Genom Med       Date:  2016-01-13       Impact factor: 8.617

Review 7.  Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.

Authors:  Scott D Grosse; Lyle C Gurrin; Nadine A Bertalli; Katrina J Allen
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

8.  Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.

Authors:  Scott D Grosse; Muin J Khoury
Journal:  Genet Med       Date:  2016-09-08       Impact factor: 8.822

9.  Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.

Authors:  Alanna Kulchak Rahm; Deborah Cragun; Jessica Ezzell Hunter; Mara M Epstein; Jan Lowery; Christine Y Lu; Pamala A Pawloski; Ravi N Sharaf; Su-Ying Liang; Andrea N Burnett-Hartman; James M Gudgeon; Jing Hao; Susan Snyder; Radhika Gogoi; Ilene Ladd; Marc S Williams
Journal:  BMC Health Serv Res       Date:  2018-10-30       Impact factor: 2.655
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.